Loading organizations...
Key people at The National Foundation for Cancer Research.
The National Foundation for Cancer Research (NFCR) funds scientific breakthroughs in cancer. This non-profit provides financial support to scientists and institutions globally, prioritizing long-term, transformative projects. NFCR emphasizes discovery-oriented investigations to deepen cancer understanding, advance innovative therapies, and progress towards genomics-based solutions for future cures.
NFCR was co-founded in 1973 by Nobel Laureate Dr. Albert Szent-Györgyi and Franklin Salisbury. Their insight was the critical need for sustained, independent funding for fundamental cancer research and public education. Dr. Szent-Györgyi, a renowned scientist, established an ethos of pursuing profound biological insights, guiding the organization’s strategy against the disease.
NFCR primarily supports cancer scientists and research institutions pursuing pioneering studies. The foundation's overarching vision is the complete eradication of cancer. It champions persistent, discovery-oriented inquiry, believing this will yield comprehensive cures for all disease forms, impacting global public health.
The National Foundation for Cancer Research has 1 tracked investment across 1 company. The latest tracked deal is $5.0M Series A in TellBio in May 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 10, 2021 | TellBio | $5.0M Series A | Andy Theurer, Crocker Ventures, Genetron Health, The National Foundation For Cancer Research | — |
Key people at The National Foundation for Cancer Research.
